The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Neratinib|DRUG: AZD5363|DRUG: Olaparib|DRUG: AZD6738
Sponsor: Institute of Cancer Research, United Kingdom
Collaborators: Royal Marsden NHS Foundation Trust